News

Omdia, a renowned global market research authority, has recently released its "Omdia Market Radar: Cloud Platforms ...
Claude Opus 4.1 scores 74.5% on the SWE-bench Verified benchmark, indicating major improvements in real-world programming, bug detection, and agent-like problem solving.
Key Points Earnings per share (Non-GAAP) came in at $0.32, surpassing the $0.28 analyst estimate (non-GAAP) Revenue (GAAP) reached $364.1 million, slightly ahead of estimates and up 10.2% ...
It’s Christmas in August – at least, for those tech-wonks who are interested in new model releases. Today’s news is a very ...
Propel Health Communications, a 2025 MM+M Agency 100 honoree, hired Christopher Thorn as SVP, creative director and Lauren Schulz as SVP of client services. DiaMedica announced the appointment of ...
IPO stock Hinge HealthHNGE launched to a record high Wednesday on a big beat in its first quarter as a publicly traded company.During the second quarter, Hinge Health generated $139.1 million in sales ...
Discover Q2 2025 highlights from Royalty Pharma (RPRX): double-digit growth, raised guidance, a $2B partnership, efficient cost structure, & ...
Shantanu Narayen, Reshma Kewalramani, Neal Mohan, Mukesh Ambani and Gautam Adani also make the Fortune 100 Most Powerful ...
ViewSonic Corp., a leading global provider of visual solutions, today announced the launch of the 6th ColorPro Awards Global ...
Google launches Gemini CLI GitHub Actions, a free AI coding teammate, and a new suite of specialized data agents to ...
We recently published 10 Big Names Bleed Double Digits. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is one of the ...
Discover key insights from Vertex, Inc.'s Q2 2025 earnings: solid revenue growth, macro challenges, and a focus on e-invoicing opportunities.